INR 147.85
(-7.3%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -104.81 Million | 174.21 Million | -249.19 Million | -30.52 Million | 20.46 Million | -96.87 Million |
Net Income | 173.04 Million | 157.45 Million | 101.08 Million | 40.16 Million | 71.86 Million | 25.15 Million |
Depreciation & Amortization | 49.99 Million | 22.61 Million | 26.46 Million | 24.58 Million | 26.85 Million | 24.19 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -394.28 Million | -72.73 Million | -424.54 Million | -123.19 Million | -108.86 Million | -159.52 Million |
Other non-cash items | 397.12 Million | 134.06 Million | 310.34 Million | 100.48 Million | 154.87 Million | 216.41 Million |
Investing Cash Flow | -152.1 Million | -228.32 Million | -16.45 Million | -17.52 Million | -6.65 Million | -68.47 Million |
Investments in PPE | -137.94 Million | -151.72 Million | -16.73 Million | -18.79 Million | -6.65 Million | -68.33 Million |
Acquisitions | 1.03 Million | 7.09 Million | 283 Thousand | 1.26 Million | - | - |
Investment purchases | -15.99 Million | -83.68 Million | - | - | -1000.00 | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 800 Thousand | - | - | - | 1000.00 | -143 Thousand |
Financing Cash Flow | 257.17 Million | 41.5 Million | 278.44 Million | 48.09 Million | -15.03 Million | 165.24 Million |
Debt repayment | -282 Million | -37.07 Million | -86.89 Million | -44.94 Million | -16.5 Million | -163.42 Million |
Dividends payments | -13.09 Million | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 361.01 Million | - | - | - |
Other Financing Activities | -11.73 Million | 4.42 Million | 4.32 Million | 3.14 Million | 1.46 Million | 1.82 Million |
Accounts receivables | -449.18 Million | -176.66 Million | -139.52 Million | -63.92 Million | 1.02 Million | -219.95 Million |
Accounts payables | 210.81 Million | 249.71 Million | -118.97 Million | 60.23 Million | 23.84 Million | 86.51 Million |
Inventory | 7.66 Million | -94.99 Million | 48.88 Million | -19.72 Million | -95.42 Million | -21.27 Million |
Other working capital | -163.58 Million | -50.79 Million | -214.92 Million | -99.78 Million | -38.3 Million | -4.8 Million |
Cash at beginning of period | 3.36 Million | 16.03 Million | 3.24 Million | 3.19 Million | 4.42 Million | 4.53 Million |
Cash at end of period | 3.5 Million | 3.36 Million | 16.03 Million | 3.24 Million | 3.19 Million | 4.42 Million |
Capital Expenditure | -137.94 Million | -151.72 Million | -16.73 Million | -18.79 Million | -6.65 Million | -68.33 Million |
Effect of forex changes on cash | - | -69.99 Thousand | -1001.00 | -1000.00 | - | - |
Net cash flow / Change in cash | 136 Thousand | -12.67 Million | 12.79 Million | 49 Thousand | -1.23 Million | -107 Thousand |
Free Cash Flow | -242.75 Million | 22.49 Million | -265.93 Million | -49.31 Million | 13.8 Million | -165.2 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 173.04 Million | 112.16 Million | 60.87 Million | 90.68 Million | 157.45 Million | 66.77 Million |
Depreciation & Amortization | 49.99 Million | 28.05 Million | 21.93 Million | 13.36 Million | 22.61 Million | 9.25 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -394.28 Million | -174.87 Million | -219.4 Million | -64.57 Million | -72.73 Million | -8.16 Million |
Other non-cash items | 397.12 Million | 16.05 Million | 381.07 Million | 40.77 Million | 134.06 Million | 93.29 Million |
Investing Cash Flow | -152.1 Million | -58.75 Million | -93.34 Million | -205.41 Million | -228.32 Million | -22.9 Million |
Investments in PPE | -137.94 Million | -65.89 Million | -72.05 Million | -122.73 Million | -151.72 Million | -28.99 Million |
Acquisitions | 1.03 Million | 945 Thousand | 90 Thousand | 1 Million | 7.09 Million | 6.09 Million |
Investment purchases | -15.99 Million | 5.39 Million | -21.38 Million | -83.68 Million | -83.68 Million | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 800 Thousand | 800 Thousand | - | - | - | - |
Financing Cash Flow | 257.17 Million | 22.1 Million | 235.07 Million | 124.41 Million | 41.5 Million | -82.91 Million |
Debt repayment | -282 Million | -35.6 Million | -246.39 Million | -121.88 Million | -37.07 Million | -84.8 Million |
Dividends payments | -13.09 Million | -13.09 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -11.73 Million | -403 Thousand | -11.32 Million | 2.53 Million | 4.42 Million | 1.89 Million |
Accounts receivables | -449.18 Million | -123.13 Million | -326.05 Million | -34.58 Million | -176.66 Million | -142.08 Million |
Accounts payables | 210.81 Million | 241.25 Million | -30.44 Million | 121.19 Million | 249.71 Million | 128.51 Million |
Inventory | 7.66 Million | -36.55 Million | 44.22 Million | -59.5 Million | -94.99 Million | -35.49 Million |
Other working capital | -163.58 Million | -256.44 Million | 92.86 Million | -91.68 Million | -50.79 Million | 40.89 Million |
Cash at beginning of period | 3.36 Million | 33.49 Million | 3.36 Million | 3.81 Million | 16.03 Million | 16.03 Million |
Cash at end of period | 3.5 Million | 3.5 Million | 33.49 Million | 3.36 Million | 3.36 Million | 3.81 Million |
Capital Expenditure | -137.94 Million | -65.89 Million | -72.05 Million | -122.73 Million | -151.72 Million | -28.99 Million |
Effect of forex changes on cash | - | - | 71 Thousand | -70 Thousand | -69.99 Thousand | 1.00 |
Net cash flow / Change in cash | 136 Thousand | -29.99 Million | 30.12 Million | -453 Thousand | -12.67 Million | -12.21 Million |
Free Cash Flow | -242.75 Million | -59.03 Million | -183.72 Million | -42.1 Million | 22.49 Million | 64.59 Million |
6955
JAN
CCRRF
TYNPF
PROF-B
102260